Objectives Eighty-two percent of human immunodeficiency virus (HIV)–positive adolescents
live in Sub-Saharan Africa (SSA). Despite the availability of antiretroviral therapy (ART) …

Objective: Adolescent and young adult (AYA) populations (12–24 years) represent over 40%
of new HIV infections globally. Adolescence is sometimes characterized by high-risk sexual …

Adolescents living in low-and middle-income countries (LMICs) are disproportionately
burdened by the global HIV/AIDS pandemic. Maintaining medication adherence is vital to …

Adolescents and youth living with HIV have poorer antiretroviral treatment (ART) adherence
and viral suppression outcomes than all other age groups. Effective interventions promoting …

Introduction Globally, an estimated 30% of new HIV infections occur among adolescents (15–
24 years), most of whom reside in sub-Saharan Africa. Moreover, HIV-related mortality …

Background Around 3.3 million children worldwide are infected with HIV and 90% of them
live in sub-Saharan Africa. Our study aimed to estimate adherence levels and find the …

Introduction Adherence to antiretroviral therapy (ART) is known to be challenging among
adolescents living with HIV/AIDS, notwithstanding the life-saving importance of this therapy …

Background Adolescents have gained increased attention because they are the only age
group where HIV related mortality is going up. We set out to describe the level and factors …

Background Adolescents living with HIV face substandard outcomes along the continuum of
care, including higher rates of poor adherence and virologic failure. Support groups have …

Introduction: Globally adolescents and young adults account for more than 40% of new HIV
infections, and HIV‐related deaths amongst adolescents increased by 50% from 2005 to …